Apotex Health Shares Jump 17% on TSX Debut, Signaling Pricing Gap

Apotex Health opened at C$28 on June 10, 2026, roughly 17% above its C$24 IPO price, creating a gap between what institutional investors paid and what secondary markets cleared. The jump reveals the tension inherent in IPO pricing: top-of-range deals can still undershoot day-one sentiment. Whether this signals a soft institutional allocation or merely reflects genuine retail demand will matter for the next Canadian healthcare issuer eyeing the primary market.